本文已被:浏览 184次 下载 162次
Received:March 04, 2026 Published Online:October 23, 2026
Received:March 04, 2026 Published Online:October 23, 2026
中文摘要: 目的 探讨右美托咪定鼻喷雾剂对腹腔镜胆囊切除患者术后睡眠相关指标、血清炎症因子及神经递质水平的影响。方法 选取2023年10月至2025年10月南京市第一医院首台腹腔镜下胆囊切除术患者60例。采用随机数字表法分为对照组和右美托咪定组,再根据入院午夜唾液褪黑素水平分为正常水平亚组(10~40 pg/mL)、低水平亚组(<10 pg/mL),两组正常水平亚组均为16例,低水平亚组均为14例。对照组进行常规临床护理及诊疗方案,右美托咪定组入院次日至出院前一日,每晚10:00及30 s后,两侧鼻腔各喷入右美托咪定鼻喷雾剂2次,每次1喷(每侧两次共计100 μg)。两组均接受同质化的麻醉方案及管理。记录入院及出院时患者午夜唾液褪黑素水平空腹血清炎症因子[白细胞介素(IL)-8、肿瘤坏死因子-α(TNF-α)、IL-6]、皮质醇(Cor)以及神经递质[去甲肾上腺素(NE)、多巴胺(DA)、5-羟色胺(5-HT)和乙酰胆碱(Ach)]水平。结果 午夜褪黑素水平在右美托咪定组正常水平亚组患者出院时高于对照组正常水平亚组[(22.95±4.75)pg/mL vs(11.35±5.05)pg/mL,t=6.689,P<0.01],在右美托咪定组低水平亚组和对照组低水平亚组患者出院时差异无统计学意义[(6.35±3.15)pg/mL vs(9.25±4.45)pg/mL,t=1.991,P=0.057]。入院时,两组血清IL-8、TNF-α、IL-6、Cor、NE、DA、5-HT、Ach水平差异均无统计学意义(P>0.05);出院时与对照组相比,右美托咪定组IL-8、TNF-α、IL-6、Cor、NE、DA水平均更低,5-HT、Ach水平均更高(P<0.05)。结论 右美托咪定鼻喷雾剂可提高基线午夜唾液褪黑素水平正常患者出院时的午夜唾液褪黑素水平,但在基线低水平患者中未观察到显著作用;同时其可能减轻围手术期炎症和神经内分泌指标的异常变化。
Abstract:Objective To explore the effects of dexmedetomidine nasal spray on postoperative sleep-related indicators,serum inflammatory factors,and neurotransmitter levels in patients undergoing laparoscopic cholecystectomy.Methods Sixty patients undergoing the first scheduled laparoscopic cholecystectomy of the day were selected from Nanjing First Hospital between October 2023 and October 2025. Using a random number table method,the subjects were divided into a control group and a dexmedetomidine group,and then based on the midnight salivary melatonin levels at admission,they were further divided into a normal level subgroup(10-40 pg/mL)and a low level subgroup(<10 pg/mL),and both groups had 16 cases in the normal level subgroup and 14 cases in the low level subgroup. The control group received routine clinical nursing and diagnosis-treatment protocols. For the dexmedetomidine group ,from the day after admission to the day before discharge,at 10:00 p.m. each night and 30 seconds later,dexmedetomidine nasal spray was administered to each nostril twice,one spray each time(total of 100 μg for the two doses each side). Both groups received standardized anesthesia protocols and management. Midnight salivary melatonin levels,fasting serum levels of inflammatory factors[interleukin(IL)-8,tumor necrosis factor-α(TNF-α),IL-6],cortisol(Cor)and neurotransmitters[norepinephrine(NE),dopamine(DA),5 - hydroxytryptamine (5 - HT)and acetylcholine(Ach)]were recorded at admission and discharge. Results At discharge,compared with the normal level subgroup of the control group,the midnight melatonin level in the normal level subgroup of dexmedetomidine group was higher [(22.95±4.75)pg/mL vs(11.35±5.05)pg/mL,t=6.689,P<0.01],while there was no significant difference between the patients in the low level subgroups of dexmedetomidine group and control group[(6.35±3.15)pg/mL vs(9.25±4.45)pg/mL,t=1.991,P=0.057]. At admission,there were no statistically significant differences between the two groups in serum levels of IL-8,TNF-α,IL-6,Cor,NE,DA,5-HT,and Ach(P>0.05). At discharge,compared with the control group,the levels of IL-8,TNF-α,IL-6,Cor,NE and DA in dexmedetomidine group were lower,and the levels of 5-HT and Achwerehigher(P<0.05).Conclusion Dexmedetomidine nasal spray can increase midnight salivary melatonin levels at discharge in patients with normal baseline melatonin levels,whereas no significant effect is observed in patients with low baseline levels. It may also attenuate perioperative alterations in inflammatory and neuroendocrine markers.
文章编号: 中图分类号:R619 文献标志码:A
基金项目:
引用文本:
